"Allergan has a long-standing commitment to study the potential of BOTOX® to treat a number of different medical conditions," said Scott Whitcup, M.D., Allergan's Executive Vice President, Research ...

BOTOX® (onabotulinumtoxinA) Receives U.S. Food and Drug Administration Approval for the Treatment of Overactive Bladder for Adults Who Have an Inadequate Response to or Are Intolerant of An ...